201 related articles for article (PubMed ID: 38287839)
1. Novel Targeted Therapies for Rheumatoid Arthritis Based on Intracellular Signalling and Immunometabolic Changes: A Narrative Review.
Rahmati M; Kwesiga MP; Lou J; Tan AL; McDermott MF
Front Biosci (Landmark Ed); 2024 Jan; 29(1):42. PubMed ID: 38287839
[TBL] [Abstract][Full Text] [Related]
2. Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology.
Astorri E; Nerviani A; Bombardieri M; Pitzalis C
Curr Pharm Des; 2015; 21(17):2216-24. PubMed ID: 25760296
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
4. Biologic agents in rheumatoid arthritis: an update for managed care professionals.
Agarwal SK
J Manag Care Pharm; 2011; 17(9 Suppl B):S14-8. PubMed ID: 22073935
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.
Qiu J; Wu B; Goodman SB; Berry GJ; Goronzy JJ; Weyand CM
Front Immunol; 2021; 12():652771. PubMed ID: 33868292
[TBL] [Abstract][Full Text] [Related]
6. Futuristic Novel Therapeutic Approaches in the Treatment of Rheumatoid Arthritis.
Rai V; Patel N; Mammen SR; Chaudhary SM; Arshad S; Munazzam SW
Cureus; 2023 Nov; 15(11):e49738. PubMed ID: 38161868
[TBL] [Abstract][Full Text] [Related]
7. An overview of immunomodulatory intervention in rheumatoid arthritis.
Kavanaugh A
Drugs Today (Barc); 1999; 35(4-5):275-86. PubMed ID: 12973432
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity drives pathogenesis of rheumatoid arthritis.
Edilova MI; Akram A; Abdul-Sater AA
Biomed J; 2021 Apr; 44(2):172-182. PubMed ID: 32798211
[TBL] [Abstract][Full Text] [Related]
9. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
Bläss S; Engel JM; Burmester GR
Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
[TBL] [Abstract][Full Text] [Related]
10. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
11. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
Hodge JA; Kawabata TT; Krishnaswami S; Clark JD; Telliez JB; Dowty ME; Menon S; Lamba M; Zwillich S
Clin Exp Rheumatol; 2016; 34(2):318-28. PubMed ID: 26966791
[TBL] [Abstract][Full Text] [Related]
13. Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.
Köller MD
Core Evid; 2008 Feb; 2(3):163-72. PubMed ID: 21221183
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
15. Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis.
Freeze R; Yang KW; Haystead T; Hughes P; Scarneo S
Pharmacol Res Perspect; 2023 Aug; 11(4):e01124. PubMed ID: 37564034
[TBL] [Abstract][Full Text] [Related]
16. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria Transfer to CD4
Giwa R; Brestoff JR
Immunometabolism; 2022; 4(2):. PubMed ID: 35444834
[TBL] [Abstract][Full Text] [Related]
18. The interplay between inflammation and metabolism in rheumatoid arthritis.
Chimenti MS; Triggianese P; Conigliaro P; Candi E; Melino G; Perricone R
Cell Death Dis; 2015 Sep; 6(9):e1887. PubMed ID: 26379192
[TBL] [Abstract][Full Text] [Related]
19. Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.
Zimmerman DH; Szekanecz Z; Markovics A; Rosenthal KS; Carambula RE; Mikecz K
Front Immunol; 2024; 15():1334281. PubMed ID: 38510240
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rheumatoid arthritis: Unraveling the conundrum.
Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
